Levetiracetam in progressive myoclonic epilepsy
- 24 February 2004
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 62 (4) , 640-643
- https://doi.org/10.1212/01.wnl.0000110193.78872.dd
Abstract
The authors conducted an open study of levetiracetam as add-on therapy in nine patients with well-defined progressive myoclonic epilepsies and refractory myoclonus. Myoclonus was evaluated semiquantitatively (territory, intensity, daily living activities). Five patients had improvement of their myoclonus score. Levetiracetam may benefit myoclonus in progressive myoclonic epilepsy.Keywords
This publication has 9 references indexed in Scilit:
- Risk Factors for Mild Cognitive Impairment in the Cardiovascular Health Study Cognition StudyArchives of Neurology, 2003
- Desynchronizing effect of levetiracetam on epileptiform responses in rat hippocampal slicesNeuroReport, 2003
- Efficacy of levetiracetam in a patient with Unverricht-Lundborg progressive myoclonic epilepsyNeurology, 2003
- Suppression of cortical myoclonus by levetiracetamMovement Disorders, 2002
- Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetamNeurology, 2001
- Antimyoclonic effect of levetiracetamEpileptic Disorders, 2000
- Piracetam and levetiracetam: close structural similarities but different pharmacological and clinical profilesEpileptic Disorders, 2000
- Zonisamide for progressive myoclonus epilepsy: long-term observations in seven patientsEpilepsy Research, 1998
- Familial Progressive Myoclonus Epilepsy: Clinical and Electrophysiologic ObservationsEpilepsia, 1995